Is It True That “Younger Growth Factors Grow More Hair”? Dr. Moriwaki on How Not to Oversimplify the Relationship Between Donor Age and Hair Growth Efficacy of Stem Cell Conditioned Media2026.08.11

“Conditioned media harvested from younger donors’ cells must be more potent — the growth factors are more vigorous, so surely they promote hair growth more strongly.” This is the kind of marketing copy you often encounter while researching hair regenerative medicine. But is the relationship between donor age and hair growth efficacy of stem cell conditioned media really such a simple downward slope? In clinical practice, the composition of conditioned media is determined not just by the cell donor’s age, but by a mesh of variables — culture conditions, passage number, storage handling, injection technique, and the patient’s own scalp environment. In this article, Dr. Shin Moriwaki of AVAN TOKYO Ginza tests the intuition that “younger equals better,” and organizes an honest way to think about product and clinic selection with clear acknowledgment of what can and cannot be claimed.

Key Points of This Article

・Donor age is one factor influencing the composition of stem cell conditioned media, but it does not solely determine hair growth efficacy

・Marketing copy claiming that “younger donors’ conditioned media reliably grow more hair” can conflate in vitro trends with actual clinical results on the human scalp

・Culture conditions, passage number, storage management, injection technique, and the patient’s own follicular environment shape outcomes just as strongly as donor age and hair growth efficacy

・What to look for when choosing a product is not the marketing pitch about donor age, but the regulatory notification, the Certificate of Analysis (CoA), and traceability of the manufacturing site

・In counseling, asking the physician plainly “why did you choose this particular conditioned media” is a good way to avoid poor selections

How Much Does Donor Age Actually Influence What Is Inside Stem Cell Conditioned Media?

Basic research has shown that the proliferative capacity and secretory activity of mesenchymal stem cells change with age. Some studies have reported that cells harvested from younger donors show relatively higher secretion of growth factors relevant to hair growth — VEGF, HGF, IGF-1, FGF — and this is frequently cited as the rationale for “younger donor equals better conditioned media.”

Laboratory Data Are Not the Same as Clinical Efficacy

However, high proliferative capacity in a culture dish and hair growth after conditioned media are injected into the human scalp are two entirely different layers. Before the media reach a hair follicle, they must pass through many gates: the skin barrier, degrading enzymes, blood flow, and the responsiveness of the follicular stem cells themselves. Even if donor age is favorable, if any of these steps becomes rate-limiting, the expected hair growth efficacy may fail to appear — that is the clinical reality.

Individual Variability Can Exceed Age-Related Differences

Another point that is easily overlooked is that individual variability among donors of the same age range is substantial. Even among donors in their twenties, growth factor profiles can differ by several fold. Grouping under the banner of “youth” is convenient for marketing, but the actual contents of conditioned media are shaped by an individual’s own biology, harvest site, and culture history — a genuinely composite condition.

Four Reasons Not to Take “Younger Growth Factors Grow More Hair” at Face Value — Variables Between Donor Age and Hair Growth Efficacy

Here are four angles on why one should be cautious of marketing that draws a straight line between donor age and hair growth efficacy.

1. Culture Conditions Dramatically Change the Growth Factor Profile

Stem cell conditioned media are collected from what cells secrete during culture. Whether serum is added to the medium (serum-free versus serum-containing), how oxygen concentration is controlled, and how culture duration is set — all of these dramatically change the quality and quantity of what is collected. Even young cells will not deliver the intended growth factor profile if culture conditions are not optimized.

2. Passage Number Alters Secretory Capacity

As stem cells are subcultured (passaged) repeatedly, cellular senescence markers appear and secretory capacity shifts. Even conditioned media from a young donor may lose the meaning of “young-derived” if the cells have been carried through many passages. Marketing that emphasizes only “donor youth” without addressing passage management has an important information gap.

3. Freeze-Thaw Cycles and Storage Can Damage Growth Factors

Growth factors are proteins, and repeated freeze-thaw cycles or lapses in temperature control lower their activity. No matter how young the donor is, conditioned media whose cold chain has been broken cannot deliver its intrinsic hair growth efficacy. When discussing quality, “how it was stored and delivered” often matters more in practice than “who provided it.”

4. Injection Technique and the Patient’s Own Scalp Environment

Ultimately, how much hair growth efficacy appears on the scalp depends strongly on the injection technique — depth, angle, density — and on the patient’s own follicular remaining capacity, blood flow, and skin condition. Promising hair growth efficacy solely on the strength of donor age oversimplifies this layered clinical reality.

What Patients Should Look at When Selecting a Product and a Clinic

So, in order not to short-circuit donor age and hair growth efficacy, what should patients use as their real decision criteria?

Check Public Records and the Certificate of Analysis (CoA)

Notifications filed under Japan’s Act on the Safety of Regenerative Medicine can be verified from public records. Whether a facility has filed a notification, and which cell source and manufacturing facility appear in that notification, is far more reliable information than a marketing pitch. On top of that, being able to confirm that the CoA for the conditioned media used in treatment lists sterility testing, mycoplasma, and endotoxin results carries significant weight in quality assurance. For background on scalp regenerative medicine and AGA guidelines, the Japanese Dermatological Association is a useful reference.

Questions to Ask in the Counseling Session

・The donor origin of the conditioned media used (umbilical cord, adipose, dental pulp, etc.), and why that source is chosen

・The manufacturing facility and its notification classification (Type I, II, or III)

・Whether quality tests are defined for each lot, and which tests they are

・Storage conditions and how the product is handled inside the clinic

・Injection technique (needle injection versus drug delivery, and the design of depth and density)

Whether the physician can answer these on the spot is one way to tell whether the clinic has chosen its stem cell conditioned media by “marketing language” or by “medical reasoning.” For broader information on hair regenerative medicine, see also our related hair regenerative medicine column index.

Frequently Asked Questions

Q. Is it really true that conditioned media from younger donors produces stronger hair growth?

Not uniformly. Basic research suggests that younger-derived cells tend to have higher secretory activity, but clinical hair growth efficacy is also strongly influenced by culture conditions, storage, injection technique, and the patient’s own scalp environment. Understanding donor age and hair growth efficacy as one variable among many is more consistent with clinical reality.

Q. Should I actively choose conditioned media labeled “donors limited to women in their twenties”?

The “women in their twenties” label is a strong marketing pitch, but by itself it does not guarantee quality or hair growth efficacy. Notification content, manufacturing facility, and testing systems — information that can actually be verified in public records and lot certificates — are more important criteria.

Q. Is it appropriate to ask the clinic about the donor’s age?

Absolutely. In fact, donor age, cell source, manufacturing facility, and notification classification are all items patients are entirely entitled to ask about. A clinic that cannot answer these questions is one to approach with caution.

Q. What should I prioritize even more than donor age?

The notification under the Act on the Safety of Regenerative Medicine, quality testing recorded on the Certificate of Analysis (CoA), cold-chain-inclusive storage management, and the design of the injection technique. On top of that foundation, donor source and age are best positioned as one piece of reference information, medically speaking.

Q. How can I tell whether a given conditioned media is right for me?

Your scalp condition, thinning pattern, medical history, and current medications all need individual evaluation by a physician for indication and limits. Whether the counseling session carefully explains “why this product” and “why this frequency and interval” is a good sign of a sound choice.

──────────────

Medical Supervision: Dr. Shin Moriwaki (Supervising Physician)

Member, Japan Society of Aesthetic Surgery (JSAS)

Member, American Academy of Aesthetic Medicine

ECFMG Certificate

──────────────

📍AVAN TOKYO Ginza Hair Regenerative Medicine

AVAN TOKYO Ginza Hair Regenerative Medicine

English / 中文 / Tiếng Việt supported

Inquiries welcome via DM / LINE / Website / Phone.